Skip to content

BloodSafe 4.x.x

by Haemonetics Corporation

BloodSafe 4.x.x is a Class II device made by Haemonetics Corporation, listed under FDA premarket submission BK140133 and listed in FDA GUDID since 15 Dec 2016 (UDI-DI 00812747010019), active as of 22 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

510(k) BK140133

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00812747010019 UDI-DI Date15 Dec 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k) from GUDID NumberBK140133 Date—StatusActive

Official records

Across registries

2 registries list this device

  • FDA premarket submission BK140133 Active
  • FDA GUDID UDI-DI 00812747010019 listed 15 Dec 2016 Listed

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
BloodSafe
Generic name
Clinical laboratory information system application software
Model / reference
4.x.x
Primary DI / UDI-DI
00812747010019
FDA product code
MMH
GMDN term
Clinical laboratory information system application software
Device class
Class II
Regulation number
864.9165
GUDID distribution status
In Commercial Distribution

Other devices from Haemonetics Corporation

See all devices from Haemonetics Corporation →

Properties

  • Prescription use
  • Lot / batch number
Other properties (13, all answered No)